Found vs Hers: Compounded Plans vs FDA-Approved Wegovy

Found vs Hers compares two telehealth approaches to GLP-1 weight-management options. Quick verdict: Found emphasizes a biology-first, personalized program with options that include compounded GLP-1s and insurance handling starting as low as $39, while Hers focuses on FDA-approved brand-name Wegovy® and related check-ins with prices from $149/mo and a required membership.

Get started with Found from as low as $39

Found vs Hers: key differences in approach and medication

The comparison centers on five distinctive differences: starting price and pricing model, medication type and regulatory status, personalization and clinical focus, insurance and Medicare handling, and membership requirements. Below, each point draws directly from the supplied source material.

1. Starting price and pricing model

Found advertises “get started for as low as $39” and lists multiple plan price points including membership and medication pricing language. Hers lists medication pricing such as “Wegovy® pill from $149/mo” and “injectable from $199/mo,” and notes that an active Hers Weight Loss Membership is required (“$39 for the first month, auto-renews at $149/month thereafter”).

See Found pricing and plans

2. Medication type and regulatory notes

Found offers compounded semaglutide and tirzepatide options and explicitly states “Compounded GLP-1s are not FDA- approved or evaluated for safety or efficacy, and not available in all states.” Hers emphasizes FDA-approved brand-name Wegovy® (“Wegovy® and Zepbound® are FDA-approved for weight loss”) and states it does not offer compounded medications.

3. Personalization and clinical focus

Found markets a “biology-first” personalized medically supervised program that “builds a personalized program around each patient’s individual metabolic biology, including hormones, blood sugar regulation, sleep, and behavioral factors.” Hers highlights a “personalized care team with ongoing dose check-ins” focused on FDA-approved brand medications. Both describe ongoing clinical oversight but frame it differently: Found around whole-body biology, Hers around brand-name GLP-1 dosing and check-ins.

4. Insurance, Medicare, and paperwork

Found states “Most insurance now accepted” and claims it can “handle insurance paperwork,” noting specific Medicare Bridge language such as “Get Wegovy®, Foundayo®, or Zepbound® for as little as $50/mo through Medicare” for eligible Part D members, and that advertised pricing and coverage vary. Hers states “No insurance required” and lists price-from values; Hers also notes medications are available only when a licensed clinician deems it appropriate and that prescription and state availability are limited.

5. Membership and availability

Found references membership options and variable plan pricing and offers flexible cancellation language. Hers requires an active membership for medication access and specifies membership billing details and that medication is not available without an active membership. Both note that prescriptions are subject to clinician review and clinical eligibility and that availability is not universal.

Comparison table: Found vs Hers

How to choose between Found and Hers

Choose Found if you prioritize a biology-first, holistic program that accepts most insurance, offers compounded GLP-1 options, and advertises a low entry point such as “as low as $39.” Choose Hers if you want FDA-approved brand-name Wegovy® with a structured membership, ongoing dose check-ins, and no compounded medications. Both require clinician review and clinical eligibility for prescriptions and note availability limits by state or program.

Start Found’s biology-first program

In short, Found vs Hers comes down to compounded versus FDA-approved brand options, differing pricing and membership models, and whether insurance handling or guaranteed brand-name medication is a priority. Verify clinical eligibility, state availability, and exact pricing with each provider before enrolling. Found vs Hers should be decided based on those qualifiers and which approach aligns with your priorities.